|
Kenneth P. Fallon III has served as a director of Osteotech since June 1995 and as Chairman of the Board since November 2005. Since March 2004 Mr. Fallon has been an Associate with Kairos Partners an investment firm and a shareholder that owns approximately 9.7% of the Company's outstanding stock. Mr. Fallon retired as the Chairman of the Board of Axya Medical Inc. a Massachusetts based privately held medical device company in March 2003 and was the Chief Executive Officer of Axya Medical Inc. from May 1999 until December 2002. In 1997 and 1998 Mr. Fallon was President of the surgical business at Haemonetics Corporation. In 1994 and 1995 Mr. Fallon served as Chief Executive Officer and Chairman of the Board of UltraCision Incorporated a manufacturer of advanced technology medical devices. UltraCision was sold to Ethicon EndoSurgery a unit of Johnson & Johnson Inc. in November 1995. From 1992 through 1994 Mr. Fallon served as President and Chief Executive Officer of American Surgical Technologies Corporation. Mr. Fallon was President U.S. Operations of Zimmer Inc. then a subsidiary of Bristol-Myers Squibb Company from 1991 to 1992. From 1985 through 1991 he served as President of Zimmer's Orthopedic Implant Division and from 1983 to 1985 as its Vice President of Marketing. Mr. Fallon previously served in positions of significant responsibility with the Codman and Orthopedic Divisions of Johnson & Johnson Inc. Mr. Fallon is also a director of Conformis Inc. a privately held medical device firm. Mr. Fallon has a B.B.A. degree in marketing from the University of Massachusetts and a M.B.A. degree from Northeastern University.
| 